Brett Molina Walmart will launch its own brand of insulin, which the retailing giant says will “revolutionize the access and affordability” of diabetes treatments. In a statement Tuesday, Walmart said it will offer analog insulin vials and FlexPens for administering doses through its ReliOn brand. The retailer claims its insulin options will save customers between 58% to...
